Is dose modification of 6-mercaptopurine necessary for patients with nudt15 variant in early intensification therapy for childhood acute lymphoblastic leukemia?
PEDIATRIC BLOOD & CANCER(2024)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
PEDIATRIC BLOOD & CANCER(2024)